Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
2021 · Frontiers in Cardiovascular Medicine · 14 citations
https://doi.org/10.3389/fcvm.2021.752468
L
Lung‐Chih Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.2K
Citations
18
h-index
30
i10-index
Lung‐Chih Li is an academic researcher from Chang Gung University. The author has contributed to research in topics: Dialysis and Renal Disease Management & Chronic Kidney Disease and Diabetes & Parathyroid Disorders and Treatments. The author has an h-index of 18, co-authored 49 publications.
ORCID: 0000-0002-1808-0083Papers by this author
worksImpaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease
2019 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-019-56381-3
Effect of inflammatory cytokines and Golgi glycosylation enzyme inhibitors on protein translocation of SCAP from ER to Golgi in THP-1 macrophages.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0075650.g005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat